determines the activation patterns during the arrhythmia. The purpose of this study is to analyze the activation frequencies during VF in isolated perfused healthy human hearts without the interference of extrinsic factors that could modulate the VF activation patterns. Methods: Three explanted hearts not suitable for cardiac transplantation obtained from donors without structural cardiac disorders were used to obtain multiple transmural recordings with transmural needles (n=24), each equipped with four unipolar electrodes (interelectrode distance = 4 mm). Informed consent was obtained from the relatives of the deceased patients, and the study was approved by the Ethical Review Board. Hearts were perfused according to the Langendorff technique with whole blood, and the electrodes were inserted in the left, and right ventricular myocardium. Spectral techniques were applied to analyze the VF recordings obtained during the electrically induced arrhythmia. The dominant frequency of the spectrum was obtained in each channel. Results: The highest mean dominant frequencies were obtained in the subendocardium of the posterior part of both the left ventricle (8.9±1.8 Hz vs 6.4±1.5 Hz in anterior wall, p<0.0001), and the right ventricle (7.1±1.1 Hz vs 6.3±1.0 Hz in anterior wall, p<0.05). The location of the maximum values varied in each of the three cases, corresponding to the posterior wall of the left ventricle in one case (11.3 Hz), the posterior wall of the right ventricle in another (7.6 Hz), and the posterior zone of the junction between septum and right ventricle in the third (8.6 Hz). In the left ventricle no clear endo-to epicardial gradients were observed, though the right ventricle tended towards slightly higher values in the subendocardial recordings.
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Multi-directional ventricular conduction on magnetocardiography predicts poor prognosis after CRT implantation
Backgrounds: Cardiac resynchronization therapy (CRT) is an established option for advanced heart failure (HF) with electro-mechanical dyssynchrony. However, it provides no benefit in an approximately one third of the patients, which is unpredictable by any clinical tool. We hypothesized that (1) magnetocardiography (MCG) capable of delineating ventricular conduction sequences with high spatiotemporal resolution identify heterogeneous (multi-directional) left ventricular (LV) intraventricular conduction (presumably indicative of local block) and that (2) it would hamper the CRT effect, thereby predicting poor prognosis after CRT implantation. Methods: We analyzed 64-Ch MCGs (1kHz) in 52 patients with advanced HF (LVEF 25±9%) and QRS prolongation (147±31ms) on ECG before CRT implantation. According to the QRS current arrow mapping, they were divided into Group-A with uni-directional homogeneous ventricular conduction (n=33) and Group-B with multi-directional heterogeneous ventricular conduction patterns (n=19). CRT responder was defined when LVESV decreased >15% or LVEF increased >15%. Results: Baseline LVEF, BNP, and NYHA class were comparable between the groups. After 6 months, responders were more frequently found in Group-A (27/33) than p<0.01) . More importantly, during the mean follow-up of 637 (105-2042) days, Kaplan-Meier analysis revealed a marked difference in mortality (death and LVAD implant, 0/33 in Group-A, 8/19 in Group-B, p<0.001).
MCG conduction patterns and Prognosis
Conclusions: Our MCG analysis indicated that prolonged but homogeneous LV conduction may represent a characteristic of the candidate who potentially benefits from CRT, while the presence of multi-directional heterogeneous conduction may negate the efficacy of CRT, thereby predicting poor prognosis after CRT implantation. Background: Since their invention, cardiac pacemakers have provided significant lifesaving therapy for millions of people. However, a device small enough to be placed within the heart would eliminate the pocket and the lead and thereby many of the modern pacemaker complications. We have created a 7-year VVIR pacemaker with a volume less than 1 cc that can be placed directly within the heart. In this study, we assessed the performance of the device design by comparing the pacing thresholds, R-wave amplitudes, and impedances of leadless pacemaker prototypes using three separate methods of measurement. Methods: One prototype was placed in the RV apex in each of 16 sheep via the jugular vein for a period of 6 weeks. The prototypes were constructed of a titanium main body, a distal titanium nitride coated pacing electrode with steroid, and a proximal titanium nitride ring. To allow direct measurement of the electrode potentials and currents, the electrodes were externalized through small wires that exited the prototype at the proximal end, passed through the jugular vein, and crossed the skin between the shoulder blades. The pacing thresholds, impedance and R-wave amplitudes were measured with both a breadboard of the pacemaker circuitry and a Medtronic 2290 pacing system analyzer at implant, and each week for 6 weeks.
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Assessment of leadless pacemaker performance
Results:
The pacing thresholds at 0.2 ms and the R-wave amplitudes measured with both the analyzer and the breadboard can be seen in Figure 1 . The measurements were similar between the two methods for both the threshold and R-wave measurements. In addition, both the thresholds and the R-wave amplitudes were stable over the 6 week study.
Pacing Thresholds and R-wave Amplitudes
Conclusions: From this study we conclude that the leadless pacemaker accurately measures pacing thresholds and R-wave amplitudes.
PRACTICAL ASPECTS OF BIOMARKERS IN HEART FAILURE
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Prognostic value of NT-pro-C-type natriuretic peptide (NT-proCNP) in heart failure patients with preserved and reduced ejection fraction Background: BNP and NT-pro-BNP are established markers in chronic heart failure (HF). C-type Natriuretic Peptide (CNP) belongs to the same peptide family. No data are available of CNP as marker in HF. Objective: To assess the prognostic power of the N-terminal part of pro-CNP (NT-proCNP) in HF. Methods: In 571 patients, NT-proCNP was measured at discharge. Primary endpoint was a composite endpoint of all-cause mortality and HF hospitalization after 18 months. Secondary endpoint was all-cause mortality after 3 years. Results: Mean age was 71±11 years, 62% was male and left ventricular ejection fraction (LVEF) was 32±14%. In a multivariate linear regression model, NTproCNP showed a positive correlation with NT-proBNP and a negative correlation with renal function and female sex. 240 Patients reached the composite endpoint and 234 died. Interaction analysis revealed a strong interaction between NT-proCNP and LVEF for both endpoints (p-value for interaction: 0.003 respectively 0.008). Therefore further analysis was stratified into patients with a reduced (HFrEF) or preserved (HFpEF) LVEF. In multivariate analyses, each doubling of NT-proCNP was strongly predictive for both the primary (HR 1.72; 95% C1 
Conclusions:
We conclude that CKD and atrial fibrillation but not hypertension are associated with the occurrence of increased NT-pro-BNP in elderly population. On contrary, overweight or obesity are associated with lower level of NT-pro-BNP in elderly. Purpose: Left ventricular remodelling following ST-elevation myocardial infarction (STEMI) is associated with worse outcomes. NTproBNP is a predictor of LV systolic impairment and adverse outcomes. We assessed the relationship of NTproBNP with infarct characteristics assessed by cardiac magnetic resonance (CMR) in patients presenting with first STEMI treated by primary percutaneous coronary intervention (PPCI). Methods: Forty-seven consecutive patients (mean age 60.5±12.3 years, 42 male) with first STEMI treated by PPCI (median time to reperfusion 150 minutes, IQR 120 minutes) had NTproBNP levels sampled during admission (median 42 hours, IQR 25 hours). Patients underwent CMR examination (median day 2, IQR 2 days) with follow up CMR at 4 months. Spearman's rank correlation was used to assess the association between admission NTproBNP and infarct characteristics, and subsequent left ventricular end systolic volume index (LVESVI) and ejection fraction (EF) at 4 months. Regression analysis of CMR assessed infarct characteristics was used to determine univariate and multivariate predictors of NTproBNP, and NTproBNP was compared to CMR assessed infarct characterisitcs to determine remodelling assessed as LVESVI and EF at four months. Results: Infarct size (IS), microvascular obstruction (MVO), intramyocardial haemorrhage (IMH), Oedematous Area-at-risk (AAR) and myocardial salvage index (MSI) all correlated with admission NTproBNP, and were significant univariate predictors of NTproBNP. On multivariate regression analysis entering all infarct measures, MVO remained the only significant predictor of NTproBNP (r2=0.572, p=0.019). NTproBNP, IS, MVO, IMH and AAR correlated significantly with 4 month EF while NTproBNP, MVO and IMH correlated significantly with ESVI at 4 months. These were entered into multivariate linear regression analysis for predictors of ESVI and EF. NTproBNP was the only significant predictor of ESVI (r2=0.407, p<0.0005) and EF (r2=0.465, p<0 .0005) at 4 months. Conclusions: NTproBNP levels are significantly related to CMR infarct parameters. NTproBNP is a better predictor of LV remodelling (ESVI and EF at 4 months) than infarct size and CMR assessed infarct characteristics. Early NTproBNP measurement at admission might select patients at subsequent risk of LV remodelling.
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What is normal left ventricular ejection fraction? a global individual person data meta-analysis of the distribution across ethnicity, gender and age K.K. Poppe on behalf of The EchoNoRMAL Collaboration. The University of Auckland, Auckland, New Zealand Purpose: Left ventricular (LV) ejection fraction (EF) is a ubiquitous measurement of systolic function used to define and assess the severity of LV dysfunction, guide management and assess prognosis. However consensus regarding the lower limit of normal EF is lacking. This study explores the distribution of EF to determine normative reference values by gender and ethnicity. Methods: We performed an individual person data meta-analysis of populationbased echocardiographic (echo)studies of volunteers. Demographics, clinical history, height, weight, BP, glucose, and echo measurements were collated. In this analysis we studied EF in adults without hypertension, diabetes, renal or cardiovascular disease. The relationship between age and the 5th centile of EF derived from 2D volume estimates (Simpson single or biplane, or area-length methods) was modelled using quantile regression. The predicted value of the 5th centile was considered the lower reference value (LRV) and is presented with a 95% confidence interval. Gender-specific models were created within each ethnic group. Data are reported for people of European (E), Asian (A) and South Asian (SA) descent, aged ≤70yrs. Results: 21317 healthy subjects from 41 studies, 50% men. EF available in: 6398 E, 926 A, 1324 SA. Among E, the LRV for EF at 50yrs was 49% for men and 50% for women. Among A, EF at 50yrs was 56% for men and 57% for women. Among SA men, EF at 50 yrs was 54% which was higher than E but lower than A. Among SA women, EF was the same as A women (57%). There were small but significant increases in the LRV across age in E men and women, and a difference in LRV suggested between genders for SA ( Conclusion: This large study shows that reference values for EF in healthy adults are associated with ethnicity, and among SA may be associated with gender. Ethnicity and gender are important factors to consider when assessing left ventricular systolic function.
